Attention Deficit Hyperactivity Disorder (ADHD or ADHD)
is one of the most common neurological disorders that begin in childhood.
Stem cell therapy of ADHD Attention Deficit Hyperactivity Disorder normalizes activity of the immune and neurvous system, blocking the autoimmune process, and thereby positively affects the functions of the central nervous system and, accordingly, speech, behavior, cognitive abilities of the child.
To neutralize lesions in the central nervous system, stem cells have the potential to: replace lost cells, provide cellular support for axonal regeneration, remyelinization (additional production of myelin, to replace lost cells), provide neurotrophic effects and promote the production of a neurotransmitter (biologically active a chemical substance by means of which an electric impulse is transmitted between neurons).
The fact that stem cells have a therapeutic potential for the treatment of ADHD and other diseases of the nervous system is evident from the fact that, after transplantation, these cells are attracted to the neurodegenerative environment, where they seem to replace dead or non-functioning cells.
Moreover, stem cells have the ability to isolate certain neurotrophic factors, such as GDNF (growth factor dopaminergic neurons from glial cells), BDNF (neurotrophic survival factor of dopaminergic neurons of black matter of the brain), and plays a role in neurotrophy.
Stem cells are used in the treatment of stroke, cerebral palsy, Parkinson’s disease, Autism, ADHD, dementia, spinal cord trauma, craniocerebral trauma, motor neuron disease (ALS), multiple sclerosis, multiple systemic atrophy, various Ataxia and other neurodegenerative diseases and various forms craniocerebral injuries.
Mesenchymal stem cells (MSCs) are obtained from the blood or fat and are cultured in laboratory.
Mesenchymal stem cells (MSCs) for ADHD treatment,
have a great potential as therapeutic agents that can migrate throughout the brain and differentiate into neurons and glial cells. In addition, they have the advantage of transdifferentiation (transformation of one type of stem cells into others), induction of angiogenesis and neurogenesis, neuroprotection and activation of endogenous neuro-reducing processes.
From all this, the advantage of MSC in choosing a type of stem cells for the treatment of ischemic and anoxic lesions of the brain develops.
Before use, MSCs are tested to ensure the safety of their use.
MSCs are introduced in the treatment of diseases of the nervous system, autoimmune diseases, diseases requiring restoration of hematopoietic and mesenchymal tissues.
Autologous stem cells (taken from the patient’s own blood or fat).
Autologous (proprietary) stem cells are used to treat patients suffering from various diseases of the nervous system and who do not wish to undergo treatment with EMBRYONIC stem cells for religious or personal reasons.
Cells derived from the patient’s own blood or fat are cultured in our laboratory for at least 2 weeks, and then injected into bloodstream of the patient.
In order to provide the patient with the most complete comprehensive medical care of ADHD , when passing treatment at the stem cell center , each patient is under the supervision of a whole team of treating physicians.